Every October, Breast Cancer Awareness Month brings a wave of screening reminders, mammogram drives, and early detection campaigns. All of that matters. Early detection saves lives. But detection is only the front half of the story. For the millions of patients who move from diagnosis into treatment and, eventually, survivorship, the harder question is rarely "did we catch it in time." It's "how is this person actually doing, six weeks or six months or six years later."
Tumor margins, staging, and recurrence rates tell a care team whether the cancer is gone. They don't tell that team how a patient is sleeping, whether fatigue is keeping her from working, or whether the emotional weight of survivorship is something she's carrying alone. That information lives with the patient, not the chart, unless someone builds a system to ask.
This is precisely the gap patient-reported outcomes (PROs) are designed to close. A PRO isn't a satisfaction survey tacked onto the end of a visit. It's a structured, validated way to capture how a patient is functioning and feeling, tracked consistently enough to show a trend rather than a single snapshot.
PatientIQ's model for outcomes collection, built and proven in orthopedics, is EHR-integrated and automated by design. A patient enrolls once, based on their care pathway, and PRO surveys are delivered on a schedule that follows them through the parts of the journey that matter most: baseline symptom burden at diagnosis, functional and quality-of-life measures through active treatment, and longer-interval check-ins during survivorship. Results land back in the clinician's workflow, not in a separate portal someone has to remember to check.
That structure is what makes the data usable. A single quality-of-life score means little. A pattern across hundreds of patients, tracked the same way over time, is something a care team or a researcher can act on.
PatientIQ's deepest track record is in orthopedics, but the platform and the underlying automation were never specialty-specific. Oncology is one of the areas we're actively expanding into, alongside neurosurgery, spine, and cardiology, because the core problem is the same everywhere: clinical teams need a scalable, low-burden way to hear from patients between visits, and researchers need clean, longitudinal data to answer questions that matter beyond a single institution.
None of this works without volume and consistency. PatientIQ's network now spans 870+ healthcare organizations and 17M+ patients enrolled, with 76M+ outcomes collected across an automated program that sustains an 80%+ blended PRO collection rate. That same infrastructure supports 3,400+ research studies, giving oncology researchers and care teams a foundation that's already been tested at scale in other specialties.
Awareness campaigns get people into the screening room. Patient-reported outcomes are what keep listening after they leave it. This October, alongside the reminders to schedule a mammogram, it's worth asking a second question: what happens to the patients who are already in treatment, and is anyone systematically checking in on how they're actually doing?